
Ibirimo Gusobanukirwa Ibimenyetso bishya bya Kanseri yumwijima muri 2026 Ibintu bishobora guteza ibyago ninde ukwiye kugenzurwa uburyo bwo gusuzuma bwo kwemeza uburyo bwo kuvura kanseri yumwijima buboneka muri 2026 Umwijima C ...
Ibirimo Gusobanukirwa Kanseri Yibanze Yibanze na 2026 Ibipimo byo Gusuzuma Yavuguruwe Amabwiriza yo Kuvura Kanseri Y’ibihaha Ntoya mu iterambere rya Kanseri Ntoya yo mu micungire ya Kanseri y’ibihaha ivura ...
Ibirimwo Ibihe bishasha vy'ubuvuzi butomoye muri Kanseri y'ibihaha Intambwe imaze guterwa muri HER2-Yagenewe Kuvura Ubuvuzi bwa KRAS Inhibitor Kuvura Ubwihindurize bwa EGFR Ubuvuzi bugamije Kugereranya Urufunguzo L ...
Ibirimo Ubwihindurize bwo Kubaga Kanseri Y ibihaha mu 2026 Intambwe imaze guterwa muri Immunotherapy ishingiye kuri Neo-Adjuvant Regimens igamije kuvura igenewe abashoferi-Mutation abarwayi beza ba tekinike yo kubaga ...
Ibirimo Ubwihindurize Bwicyiciro Cyagutse Gitoya Yokuvura Kanseri Yibihaha Iza-bren: Ihinduka rya Paradigm muri Bispecific ADC Therapy Tarlatamab hamwe no kuzamuka kwa T-selile Abashinzwe umutekano no kwihanganira muri ...
Ibirimo Gusobanukirwa nuburyo bugezweho bwa kanseri ntoya yo kuvura kanseri yibihaha Amahitamo yumurongo wa mbere: Immunotherapy Gukomatanya Kwiyongera kwa Antibody-Ibiyobyabwenge (ADCs) byibasiye DLL3: ...